Escalon Medical Corp (ESMC) Financial Statements (2024 and earlier)

Company Profile

Business Address 435 DEVON PARK ROAD
WAYNE, PA 19087
State of Incorp. PA
Fiscal Year End June 30
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
6/30/2023
12/31/2022
MRQ
6/30/2022
6/30/2021
6/30/2020
6/30/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8903135941,651826410
Cash and cash equivalents8903135941,651826410
Restricted cash and investments256256256256255253
Receivables 1,6541,1881,5421,0821,3131,496
Inventory, net of allowances, customer advances and progress billings1,5881,8841,6041,4171,7851,879
Inventory1,5881,8841,6041,4171,7851,879
Other current assets250172190187154275
Other undisclosed current assets      
Total current assets:4,6373,8144,1864,5934,3334,313
Noncurrent Assets
Operating lease, right-of-use asset5046457888441,107
Property, plant and equipment344053819768
Intangible assets, net (including goodwill)708083102122747
Intangible assets, net (excluding goodwill)708083102122747
Deposits noncurrent assets6363636363 
Total noncurrent assets:6708289861,0901,389815
TOTAL ASSETS:5,3084,6425,1725,6835,7235,127
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,8571,9812,3601,7981,4421,537
Interest and dividends payable   112
Employee-related liabilities446  102
Accounts payable1,2061,3221,0121,102761667
Accrued liabilities652659902696681657
Deferred revenue 426 332364516
Debt40249208708426205
Disposal group, including discontinued operation 87 1301369091
Due to related parties  112112112 
Other liabilities 85    
Other undisclosed current liabilities442647(141)279279427
Total current liabilities:2,8532,9623,0023,3972,8652,260
Noncurrent Liabilities
Long-term debt and lease obligation160254363890815
Long-term debt, excluding current maturities1602481215
Liabilities, other than long-term debt, including:214378 419690
Liability, pension and other postretirement and postemployment benefits      690
Other liabilities    41  
Operating lease, liability214378539630897
Other undisclosed liabilities, other than long-term debt     9 
Other undisclosed noncurrent liabilities146149(389)147429 
Total noncurrent liabilities:5205296928261,346705
Total liabilities:3,3733,4903,6944,2234,2112,965
Equity
Equity, attributable to parent1,9351,1511,4781,4601,5122,162
Preferred stock645645645645645645
Common stock777777
Additional paid in capital69,70269,70269,70269,70269,70269,702
Accumulated deficit(68,420)(69,203)(68,876)(68,895)(68,842)(68,192)
Total equity:1,9351,1511,4781,4601,5122,162
TOTAL LIABILITIES AND EQUITY:5,3084,6425,1725,6835,7235,127

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
6/30/2023
12/31/2022
TTM
6/30/2022
6/30/2021
6/30/2020
6/30/2019
Revenues12,18010,93810,70310,4729,4009,627
Cost of revenue(6,699)(6,193)(6,096)(6,044)(12)(5,003)
Cost of goods and services sold(6,699)(6,193)(6,096)(6,044) (4,997)
Provision for loan, lease, and other losses     (12) 
Gross profit:5,4814,7444,6074,4279,3884,624
Operating expenses(5,003)(5,297)(5,077)(4,461) (4,877)
Other undisclosed operating loss     (10,788) 
Operating income (loss):479(552)(470)(34)(1,400)(253)
Nonoperating income (expense)(22)(20)488(18)7493
Investment income, nonoperating 000149
Other nonoperating income   506375911
Interest and debt expense(22)(20)(18)(22)(14)(17)
Income (loss) from continuing operations before income taxes:435(593)(0)(74)(664)(267)
Income tax expense (benefit)    6610(57)
Income (loss) from continuing operations:435(593)(0)(8)(653)(324)
Loss before gain (loss) on sale of properties:(581)(0)(8)(653)(324)
Net income (loss):435(593)(0)(8)(653)(324)
Other undisclosed net income (loss) attributable to parent222018(44)374
Net income (loss) attributable to parent:457(573)18(52)(650)(250)
Preferred stock dividends and other adjustments(52)(52)(52)(51)(52)(52)
Undistributed earnings (loss) allocated to participating securities, basic (184)     
Other undisclosed net loss available to common stockholders, basic      
Net income (loss) available to common stockholders, basic:222(624)(34)(103)(702)(302)
Convertible preferred dividends521352   
Other undisclosed net income available to common stockholders, diluted13252  5252
Net income (loss) available to common stockholders, diluted:405(560)18(103)(650)(250)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
6/30/2023
12/31/2022
TTM
6/30/2022
6/30/2021
6/30/2020
6/30/2019
Net income (loss):435(593)(0)(8)(653)(324)
Comprehensive income (loss), net of tax, attributable to parent:435(593)(0)(8)(653)(324)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: